This study examined whether type 2 diabetes increases the risk of tendon rupture. The authors concluded that women with poorly controlled type 2 diabetes have a higher risk of experiencing a tendon rupture. Men with type 2 diabetes do not have a higher risk of experiencing a tendon rupture.

This study investigated the change in central retinal thickness (CRT) by optical coherence tomography (OCT) in patients with type 2 diabetes (T2D) after 12 weeks of treatment with dapagliflozin (Farxiga) or glibenclamide (Diabeta). The authors concluded that CRT may improve with short-term use of dapagliflozin compared with glibenclamide treatment.

This study investigated the effect of exenatide (EXE; Byetta) on kidney function, obesity and glucose control in overweight or obese patients with type 2 diabetes (T2D). The data showed that EXE could assist in improving kidney function, glucose control, and inflammation after 24 weeks of treatment.

This study compared the effectiveness and safety of tirzepatide to insulin degludec (Tresiba) in patients with uncontrolled type 2 diabetes (T2D). The data showed that tirzepatide produced better blood glucose control and body weight improvements with reduced risk of hypoglycemia, compared to degludec in these patients.

This study aimed to identify adults with latent autoimmune diabetes and to identify characteristics of the disease.

This study compared the effects of Lusefi (luseogliflozin) in people with type 2 diabetes (T2D) who had different carbohydrate intakes. It determined that luseogliflozin reduced glucose levels, regardless of carbohydrate intake.

This article summarizes a presentation on the treatment of autonomic diabetic neuropathy in the gut (gastroparesis). The presentation was given at the 2015 annual meeting of the European Association for the Study of Diabetes (EASD). The article concluded that the first goal of treatment is to tightly control blood sugar to prevent autonomic neuropathy from progressing.

This study examined the effect of lifetime depression and anxiety on current psychological symptoms and diabetes behavior and control in patients with type 2 diabetes (T2D).

The authors aimed to evaluate the relationship between age-related macular degeneration and diabetes. The authors concluded that diabetes was a risk factor for age-related macular degeneration (AMD) and the association was stronger in late AMD than earlier stages.